State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, P. R. China.
School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, P. R. China.
Theranostics. 2019 Mar 16;9(7):1980-1992. doi: 10.7150/thno.31073. eCollection 2019.
Myocardial infarction (MI) is identified as one of the major causes of mortality and disability worldwide. For severe myocardial infarction, even advanced forms of clinical intervention often lead to unsatisfactory therapeutic results. Thus, alternative strategies for MI treatment are still desirable. Previously studies reported the capacity of degradative fragment of h-HA (high molecular weight hyaluronic acid), hyaluronan oligosaccharides (<10 disaccharides units, o-HA), for wound healing by influence on angiogenesis, inspiring us to study its potential for myocardial functional recovery against MI. However, there are few reports about o-HA in MI therapy. : In our study, we synthesized o-HA with 610 disaccharides (4-5 kDa) by enzymatic degradation and investigated its therapeutic effects on MI. : We found that o-HA could reduce infarct size and apoptosis in MI region, also promote myocardial angiogenesis and myocardial function reconstruction in MI mouse model. Furthermore, our results also indicated that o-HA in cardiac improved polarization of M2 type macrophage, removed the inflammatory response caused by neutrophil for accelerating myocardial function reconstruction . The transcriptomic analyses revealed that o-HA could activate expression of chemokines Ccl2 and Cxcl5 for promoting macrophage polarization and stimulate MAPK and JAK/STAT signaling pathway for compensatory response of myocardial function. : Collectively, our results suggested o-HA with 610 disaccharides might be a potential agent for reconstruction of cardiac function against MI.
心肌梗死(MI)是全球范围内主要的死亡和残疾原因之一。对于严重的心肌梗死,即使是先进的临床干预手段,往往也会导致治疗效果不理想。因此,仍然需要寻找治疗心肌梗死的替代策略。先前的研究报道了 h-HA(高分子量透明质酸)的降解片段,即透明质酸寡糖(<10 个二糖单位,o-HA),通过影响血管生成,具有促进伤口愈合的能力,这启发我们研究其在心肌梗死治疗中恢复心肌功能的潜力。然而,关于 o-HA 在心肌梗死治疗中的应用,相关报道较少。
在我们的研究中,我们通过酶解合成了具有 6~10 个二糖(4-5 kDa)的 o-HA,并研究了其在心肌梗死中的治疗效果。
我们发现 o-HA 可以减少 MI 区域的梗死面积和细胞凋亡,促进 MI 小鼠模型中的心肌血管生成和心肌功能重建。此外,我们的结果还表明,o-HA 在心梗中改善了 M2 型巨噬细胞的极化,减轻了中性粒细胞引起的炎症反应,从而加速了心肌功能的重建。转录组学分析显示,o-HA 可以激活趋化因子 Ccl2 和 Cxcl5 的表达,促进巨噬细胞极化,并刺激 MAPK 和 JAK/STAT 信号通路,以代偿心肌功能。
综上所述,我们的研究结果表明,具有 6~10 个二糖的 o-HA 可能是一种治疗心肌梗死、恢复心肌功能的潜在药物。